Ad
related to: what is decitabine used for medication uses examples- Dosing With INQOVI
Oral Dosing Schedule & What To Do
If Modifications Are Needed.
- $0 Co-Pay Program
Learn How Your Eligible Patients
May Enroll For A $0 Co-Pay.
- Patient Considerations
Learn Which Patients May
Be Appropriate For INQOVI.
- INQOVI Efficacy & Safety
Learn About Trial Results
Including Safety & Efficacy.
- Why INQOVI?
Learn How INQOVI May Help Your
Patients. Access Prescribing Info.
- Watch A Panel Discussion
See Medical Professionals & A
Patient Advocate Discuss INQOVI.
- Dosing With INQOVI
Search results
Results From The WOW.Com Content Network
Decitabine (i.e., 5-aza-2′-deoxycytidine), sold under the brand name Dacogen among others, acts as a nucleic acid synthesis inhibitor. [4] It is a medication for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML). [5] Chemically, it is a cytidine ...
A hypomethylating agent (or demethylating agent [1]) is a drug that inhibits DNA methylation: the modification of DNA nucleotides by addition of a methyl group.Because DNA methylation affects cellular function through successive generations of cells without changing the underlying DNA sequence, treatment with a hypomethylating agent is considered a type of epigenetic therapy.
Azacitidine and decitabine are marketed as Vidaza and Dacogen respectively. Azacitidine is the first drug to be approved by FDA for treating MDS and has been given orphan drug status. [ 2 ] [ 3 ] Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. [ 4 ]
Azacitidine is a chemical analogue of the nucleoside cytidine, which is present in DNA and RNA.It is thought to have antineoplastic activity via two mechanisms – at low doses, by inhibiting of DNA methyltransferase, causing hypomethylation of DNA, [16] and at high doses, by its direct cytotoxicity to abnormal hematopoietic cells in the bone marrow through its incorporation into DNA and RNA ...
Decitabine/cedazuridine was approved for medical use in the United States and Canada in July 2020, [7] [8] [9] [12] and in the European Union in September 2023. [6]The U.S. Food and Drug Administration (FDA) granted the application of decitabine combined with cedazuridine priority review and orphan drug designation.
When used as drugs, the International Nonproprietary Names (INNs) end in -mab. The remaining syllables of the INNs, as well as the column Source, are explained in Nomenclature of monoclonal antibodies. Types of monoclonal antibodies with other structures than naturally occurring antibodies.
If you are a heroin addict looking to get sober, Mike Greenwell, the center’s intake supervisor, is the first man you talk to. On a Saturday night in late March, Greenwell, 61, was still at his desk doing paperwork. He used to be a nightclub manager before alcohol and drug use got the better of him. He keeps a little radio tuned to classic rock.
For example, the CHOP regimen consists of cyclophosphamide, doxorubicin, vincristine and prednisone. Besides chemotherapy, medical oncology (pharmacotherapy for cancer) includes several noncytotoxic classes of therapy, such as hormonal therapy and targeted therapy (biologic therapy). Those agents are described in the relevant articles.
Ad
related to: what is decitabine used for medication uses examples